Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong
· Delayed Price · Currency is HKD 17.56
+0.58 (3.42%)
Mar 10, 2026, 11:59 AM HKT
HKG:1681 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 14,286 | 6,771 | 3,780 | 3,193 | 3,495 | 2,439 | Upgrade
|
| Market Cap Growth | 108.90% | 79.14% | 18.38% | -8.64% | 43.27% | -37.84% | Upgrade
|
| Enterprise Value | 10,464 | 3,788 | 1,258 | 1,225 | 2,132 | 1,743 | Upgrade
|
| Last Close Price | 16.98 | 7.77 | 3.91 | 3.03 | 3.13 | 2.04 | Upgrade
|
| PE Ratio | 13.16 | 6.99 | 4.37 | 4.14 | 4.82 | 4.12 | Upgrade
|
| Forward PE | 10.78 | 6.57 | 4.09 | 4.18 | 3.80 | 3.76 | Upgrade
|
| PS Ratio | 3.99 | 2.14 | 1.33 | 1.21 | 1.39 | 1.17 | Upgrade
|
| PB Ratio | 2.81 | 1.45 | 0.88 | 0.82 | 0.98 | 0.82 | Upgrade
|
| P/TBV Ratio | 3.19 | 1.66 | 1.03 | 1.00 | 1.25 | 1.11 | Upgrade
|
| P/FCF Ratio | 11.41 | 6.51 | 4.48 | 3.15 | 4.54 | 2.51 | Upgrade
|
| P/OCF Ratio | 10.60 | 5.85 | 4.19 | 2.98 | 3.92 | 2.37 | Upgrade
|
| PEG Ratio | - | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | Upgrade
|
| EV/Sales Ratio | 2.92 | 1.20 | 0.44 | 0.46 | 0.85 | 0.84 | Upgrade
|
| EV/EBITDA Ratio | 8.45 | 3.45 | 1.27 | 1.38 | 2.38 | 2.37 | Upgrade
|
| EV/EBIT Ratio | 8.91 | 3.65 | 1.38 | 1.51 | 2.63 | 2.67 | Upgrade
|
| EV/FCF Ratio | 8.35 | 3.64 | 1.49 | 1.21 | 2.77 | 1.79 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.13 | 0.13 | 0.21 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 0.22 | 0.26 | 0.57 | 0.58 | 0.83 | 0.88 | Upgrade
|
| Debt / FCF Ratio | 0.22 | 0.27 | 0.67 | 0.51 | 0.97 | 0.67 | Upgrade
|
| Net Debt / Equity Ratio | -0.81 | -0.82 | -0.78 | -0.75 | -0.62 | -0.55 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.37 | -3.49 | -3.42 | -3.28 | -2.49 | -2.25 | Upgrade
|
| Net Debt / FCF Ratio | -3.31 | -3.68 | -4.01 | -2.88 | -2.89 | -1.70 | Upgrade
|
| Asset Turnover | 0.56 | 0.52 | 0.50 | 0.51 | 0.49 | 0.46 | Upgrade
|
| Inventory Turnover | 2.35 | 2.07 | 1.99 | 2.12 | 2.13 | 1.97 | Upgrade
|
| Quick Ratio | 3.29 | 3.09 | 2.60 | 2.47 | 2.06 | 1.80 | Upgrade
|
| Current Ratio | 3.54 | 3.32 | 2.86 | 2.68 | 2.25 | 2.00 | Upgrade
|
| Return on Equity (ROE) | 23.60% | 22.07% | 21.38% | 21.53% | 21.64% | 19.98% | Upgrade
|
| Return on Assets (ROA) | 11.58% | 10.73% | 9.93% | 9.66% | 9.93% | 8.98% | Upgrade
|
| Return on Invested Capital (ROIC) | 113.06% | 106.82% | 88.13% | 67.03% | 50.16% | 34.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.60% | 21.80% | 20.60% | 20.20% | 22.00% | 21.00% | Upgrade
|
| Earnings Yield | 7.74% | 14.31% | 22.87% | 24.18% | 20.73% | 24.28% | Upgrade
|
| FCF Yield | 8.77% | 15.37% | 22.34% | 31.73% | 22.03% | 39.84% | Upgrade
|
| Dividend Yield | 4.05% | 7.72% | 11.52% | 9.90% | 9.58% | 13.72% | Upgrade
|
| Payout Ratio | 45.94% | 74.75% | 41.59% | 18.67% | 33.56% | 26.36% | Upgrade
|
| Buyback Yield / Dilution | -6.04% | -4.12% | -0.91% | 1.58% | 1.54% | 4.35% | Upgrade
|
| Total Shareholder Return | -1.99% | 3.60% | 10.62% | 11.48% | 11.12% | 18.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.